Psychotic complications of long‐term levodopa treatment of Parkinson's disease
Identifieur interne : 002685 ( Main/Exploration ); précédent : 002684; suivant : 002686Psychotic complications of long‐term levodopa treatment of Parkinson's disease
Auteurs : A. Friedman [Pologne] ; J. Sienkiewicz [Pologne]Source :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 1991-08.
English descriptors
Abstract
ABSTRACT The prevalence of psychotic complications of levodopa treatment was assessed in 198 Parkinson patients. The symptoms were seen in 44 (22.2%). Those who developed complications were significantly older at disease onset (63.3 ± 9.2 vs 57.6 ± 11.6). The observed psychiatric symptoms were classified into two categories: simple, including incidents of confusion alone or hallucinations with preserved insight, and complex, including delusions or chronic confusion without preserved insight. Patients with complex symptoms were significantly younger at the onset of the disease, and the duration of the disease prior to these psychiatric symptoms was longer than in the group of patients with simple symptomatology. Patients with complex symptoms were more susceptible to another central side‐effect of the treatment: dyskinesias, than those with simple.
Url:
DOI: 10.1111/j.1600-0404.1991.tb04918.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title><author><name sortKey="Friedman, A" sort="Friedman, A" uniqKey="Friedman A" first="A." last="Friedman">A. Friedman</name></author><author><name sortKey="Sienkiewicz, J" sort="Sienkiewicz, J" uniqKey="Sienkiewicz J" first="J." last="Sienkiewicz">J. Sienkiewicz</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4FE2516B2E833A36FE237FE08189F7DF60868966</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1111/j.1600-0404.1991.tb04918.x</idno><idno type="url">https://api.istex.fr/document/4FE2516B2E833A36FE237FE08189F7DF60868966/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">003151</idno><idno type="wicri:Area/Main/Curation">002D52</idno><idno type="wicri:Area/Main/Exploration">002685</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Psychotic complications of long‐term levodopa treatment of Parkinson's disease</title><author><name sortKey="Friedman, A" sort="Friedman, A" uniqKey="Friedman A" first="A." last="Friedman">A. Friedman</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Neurology, Warsaw Medical Academy</wicri:regionArea><wicri:noRegion>Warsaw Medical Academy</wicri:noRegion></affiliation></author><author><name sortKey="Sienkiewicz, J" sort="Sienkiewicz, J" uniqKey="Sienkiewicz J" first="J." last="Sienkiewicz">J. Sienkiewicz</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Neurology, Warsaw Medical Academy</wicri:regionArea><wicri:noRegion>Warsaw Medical Academy</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1991-08">1991-08</date><biblScope unit="volume">84</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="111">111</biblScope><biblScope unit="page" to="113">113</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">4FE2516B2E833A36FE237FE08189F7DF60868966</idno><idno type="DOI">10.1111/j.1600-0404.1991.tb04918.x</idno><idno type="ArticleID">ANE111</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>levodopa</term><term>psychotic complications</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">ABSTRACT The prevalence of psychotic complications of levodopa treatment was assessed in 198 Parkinson patients. The symptoms were seen in 44 (22.2%). Those who developed complications were significantly older at disease onset (63.3 ± 9.2 vs 57.6 ± 11.6). The observed psychiatric symptoms were classified into two categories: simple, including incidents of confusion alone or hallucinations with preserved insight, and complex, including delusions or chronic confusion without preserved insight. Patients with complex symptoms were significantly younger at the onset of the disease, and the duration of the disease prior to these psychiatric symptoms was longer than in the group of patients with simple symptomatology. Patients with complex symptoms were more susceptible to another central side‐effect of the treatment: dyskinesias, than those with simple.</div></front></TEI><affiliations><list><country><li>Pologne</li></country></list><tree><country name="Pologne"><noRegion><name sortKey="Friedman, A" sort="Friedman, A" uniqKey="Friedman A" first="A." last="Friedman">A. Friedman</name></noRegion><name sortKey="Sienkiewicz, J" sort="Sienkiewicz, J" uniqKey="Sienkiewicz J" first="J." last="Sienkiewicz">J. Sienkiewicz</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002685 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002685 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4FE2516B2E833A36FE237FE08189F7DF60868966
|texte= Psychotic complications of long‐term levodopa treatment of Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |